clopidogrel has been researched along with Brain Hemorrhage in 73 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (10.96) | 29.6817 |
2010's | 48 (65.75) | 24.3611 |
2020's | 17 (23.29) | 2.80 |
Authors | Studies |
---|---|
Ip, A; Lau, KK; Ng, AK; Ng, PY; Siu, CW | 1 |
Huang, HY; Katz, AJ; Lin, FJ; Lin, SY; Sheu, JJ; Wang, CC; Wu, CH | 1 |
Horie, N; Hosogai, M; Ishii, D; Kuwabara, M; Maeda, Y; Mitsuhara, T; Okazaki, T; Sakamoto, S; Shimonaga, K | 1 |
Chen, Y; Li, D; Liu, S; Ma, X; Zhong, P | 1 |
Bar, M; Cernik, D; Cihlar, F; Herzig, R; Husty, J; Jura, R; Klail, T; Kocher, M; Kočí, L; Kovacova, I; Kovar, M; Mikulik, R; Nevšímalová, M; Raupach, J; Rocek, M; Sanak, D; Sedova, P; Sevcik, P; Skoloudik, D; Sramek, M; Tomek, A; Vaclavik, D; Vanicek, J; Vaško, P; Vinklarek, JF | 1 |
Ballantyne, K; Barrett, JW; Bootland, D; Da Costa, A; Davies, R; Griggs, JE; Leung, J; Lyon, RM; Skene, SS; Williams, J | 1 |
Foerch, C; Lieschke, F; Schaefer, JH; van Leyen, K; Wang, X; Zheng, Y | 1 |
Jung, JM; Kim, BJ; Kim, SM; Kwon, SU; Lee, JS | 1 |
Gong, H; Lan, L; Li, M; Li, X; Pan, J; Peng, Y; Rong, X; Shen, Q; Wang, H; Zhang, X | 1 |
Biros, MH; Coutts, SB; Cucchiara, B; Easton, JD; Elm, J; Johnston, SC; Ross, MA; Willey, JZ | 1 |
Brennan, MM; Corliss, BM; Fox, WC; Freedman, R; Harris, NS; Hoh, BL; Nerva, JD; Polifka, AJ; Smith, J | 1 |
Álvarez-Antón, S; Carballeira, D; Concepción, R; Dejuán-Bitriá, C; Del Castillo, H; Delgado-Calva, FA; López-Soberón, E; Marschall, A; Martí, D; Morales, MJ; Palazuelos, J; Pérez-Guzmán, J | 1 |
Agnoletti, V; Brogi, E; Coccolini, F; Corbella, D; Forfori, F; Gamberini, E; Russo, E | 1 |
Akhtar, IN; Akinci, Y; French, B; Gao, X; Jahngir, MU; Kraus, J; Liaqat, J; Lobanova, I; Qualls, K; Qureshi, AI; Ramiro Gomez, C; Siddiq, F; Uzun, G | 1 |
Balusson, F; Bouget, J; Lacut, K; Oger, E; Pavageau, L; Roy, PM; Viglino, D | 1 |
Barbosa, RM; Bazan, R; Germininani, FMB; Lange, MC; Lopes Neto, FDN; Massaro, AR; Scavasine, VC; Zétola, VF | 1 |
Bigliardi, G; Borzì, GM; Ciolli, L; Dell'Acqua, ML; Lelli, N; Maffei, S; Meletti, S; Pentore, R; Picchetto, L; Ricceri, R; Rodríguez-Villatoro, N; Rosafio, F; Sacchetti, F; Tondelli, M; Vallone, S; Vandelli, G; Vandelli, L; Zini, A | 1 |
Chen, C; Hu, W; Liu, D; Liu, J; Liu, T; Luo, W; Song, J; Tao, C; Yuan, X; Zhang, C; Zhu, Y | 1 |
Algra, A; Bath, PM; Csiba, L; Diener, HC; Greving, JP; Hacke, W; Hilkens, NA; Kappelle, LJ; Koudstaal, PJ; Leys, D; Mas, JL; Sacco, RL | 1 |
Belmin, J; Jarzebowski, W; Lafuente-Lafuente, C; Melkonian, M; Pautas, E; Siguret, V | 1 |
Barmparas, G; Bosarge, P; Brown, CV; Bukur, M; Carrick, MM; Catalano, RD; Coimbra, R; Holly-Nicolas, J; Inaba, K; Kaminski, S; Klein, AL; Kobayashi, L; Kopelman, T; Ley, EJ; Martinez, EM; Moore, FO; Murry, J; Nirula, R; Paul, D; Quick, J; Rivera, O; Schreiber, M | 1 |
Baschin, M; Greinacher, A; Kohlmann, T; Schroeder, HW; Selleng, S; Thiele, T; Westphal, A; Zeden, JP | 1 |
Tan, Z; Wang, W; Xiao, W; Xu, A; Yang, W; Zeng, J; Zhao, Y | 1 |
Bilker, WB; Brensinger, CM; Grosser, T; Hennessy, S; Kasner, SE; Leonard, CE; Li, X; Nam, YH | 1 |
Liu, X; Zhang, JJ | 1 |
Abu-Assi, E; Alegre, O; Alexopoulos, D; Alfonso, E; Ariza-Solé, A; Cequier, A; Chen, Y; Correia, L; D'Ascenzo, F; Fan, JY; Filipiak, K; Formiga, F; Fujii, T; Gaita, F; Garay, A; García-Acuña, JM; Giordana, F; González-Juanatey, JR; Henriques, JPS; Huczek, Z; Ikari, Y; Kalpak, O; Kawaji, T; Kawashiri, MA; Kedev, S; Kikkert, WJ; Kowara, M; Liebetrau, C; Lorente, V; Möllmann, H; Moretti, C; Nakahashi, T; Nie, SP; Nuñez-Gil, I; Osman, N; Raposeiras-Roubín, S; Sakata, K; Sánchez-Salado, JC; Saucedo, J; Shiomi, H; Song, X; Southern, D; Terol, B; Wang, X; Wilton, SB; Xanthopoulou, I; Yamagishi, M; Yan, Y; Zhang, D | 1 |
Ding, L; Peng, B | 1 |
Alexandrov, AV; Alexandrov, AW; Bryndziar, T; Chang, J; Chulpayev, B; Deep, A; Duden, P; Goyal, N; Katsanos, AH; Kerro, A; Krishnan, R; Malhotra, K; Nearing, K; Pandhi, A; Shahripour, RB; Tsivgoulis, G; Zand, R | 1 |
Carlsen, SM; Giannadakis, C; Gulati, AM; Gulati, S; Jakola, AS; Jensberg, H; Madsbu, MA; Salvesen, Ø; Solheim, O; Øie, LR | 1 |
Chang, TY; Fan, PY; Hsieh, MY; Kuo, CF; Lee, CC; Li, IJ; Liu, SH; Tian, YC; Tu, KH; Weng, CH; Wu, HH; Yang, CW | 1 |
Graipe, A; Mooe, T; Söderström, L | 1 |
Barsan, W; Easton, JD; Elm, JJ; Farrant, M; Johnston, SC; Kim, AS; Lindblad, AS; Palesch, YY; Tillman, H | 1 |
Abramson, BL; Berger, JS; Blomster, JI; Dombrowski, KE; Fowkes, FGR; Hiatt, WR; Jones, WS; Jordan, JD; Katona, BG; Kolls, BJ; Leiva-Pons, JL; Mahaffey, KW; Norgren, L; Patel, MR; Prieto, JC; Rockhold, FW; Sapp, S; Sokurenko, G | 1 |
Bilker, WB; Brensinger, CM; Cohen, JB; Hennessy, S; Leonard, CE; Nam, YH; Pham Nguyen, TP; Soprano, SE; Zhou, M | 1 |
Armstrong, PW; Arntz, HR; Bluhmki, E; Bogaerts, K; Carvalho, AC; Danays, T; Fresco, C; Gershlick, AH; Goldstein, P; Grajek, S; Halvorsen, S; Huber, K; Lambert, Y; Nanas, J; Ostojic, M; Regelin, A; Rosell Ortiz, F; Sulimov, V; Van de Werf, F; Vandenberghe, K; Welsh, RC; Wilcox, R | 1 |
Albright, KC; Beasley, TM; Boehme, AK; Jones, EM; Leung, LY; Martin-Schild, S; Pletsch, GR; Shah, KR; Siegler, JE; Tarsia, J | 1 |
Bell, PR; Bown, MJ; Dennis, MJ; London, NJ; McCarthy, MJ; Nasim, A; Naylor, AR; Sayers, RD | 1 |
Bulsara, KR; Chalouhi, N; Hasan, DM; Howard, M; Jabbour, P; Kung, DK; Mahaney, KB; Smietana, J; Viljoen, S | 1 |
Beynon, C; Jakobs, M; Jung, C; Sakowitz, OW; Scherer, M; Unterberg, AW | 1 |
Hong, KS; Lee, M; Ovbiagele, B; Rao, NM; Saver, JL; Wu, YL | 1 |
Aziz, H; Friese, RS; Joseph, B; Kulvatunyou, N; O'Keeffe, T; Pandit, V; Rhee, P; Sadoun, M; Tang, A; Wynne, JL | 1 |
Akioka, N; Hayakawa, Y; Kashiwazaki, D; Kuroda, S; Kuwayama, N | 1 |
Butvidas, L; Friese, RS; Gries, L; Joseph, B; Khalil, M; Kulvatunyou, N; Meyer, D; O'Keeffe, T; Pandit, V; Rhee, P; Tang, A; Zangbar, B | 1 |
Cervera, A; Llull, L; Martín, V; Vidal, B | 1 |
Ferrigno, L; Grotts, J; Kaminski, S; Reddy, S; Sharma, R | 1 |
Jaben, EA; Mulay, SB; Stubbs, JR | 1 |
Alarcon, LH; Bauer, J; Chen, SH; Grandhi, R; Harrison, G; Nicholas, D; Okonkwo, DO; Voronovich, Z | 1 |
Badimon, L; Bugiardini, R; Calmac, L; Cenko, E; Daullxhiu, I; Dorobantu, M; Kedev, S; Knežević, B; Koller, A; Manfrini, O; Miličić, D; Puddu, PE; Ricci, B; Trninic, D; Vasiljevic, Z | 1 |
Chalouhi, N; Daou, B; Hasan, DM; Jabbour, P; Shields, B; Starke, RM | 1 |
García Rodríguez, LA; Hennekens, CH; Lanas, A; Martín-Pérez, M; Rothwell, PM | 1 |
Fahed, E; Ghauche, J; Maarrawi, J; Menassa-Moussa, L; Moussa, R; Nohra, G; Okais, N; Rahme, R; Rizk, T; Samaha, E | 1 |
Ärnlöv, J; Carlsson, AC; Holzmann, M; Johansson, SE; Sundquist, J; Sundquist, K; Wändell, P | 1 |
Alessi, MC; Bonnet, JL; Cuisset, T; Frere, C; Quilici, J; Uhry, S | 1 |
Bair, HA; Bendick, PJ; Howells, GA; Ivascu, FA; Janczyk, RJ; Junn, FS | 1 |
Qureshi, AI; Suri, MF | 1 |
Boysen, G | 1 |
Alessi, MC; Bali, L; Bonnet, JL; Cayla, G; Cuisset, T; Frere, C; Gaborit, B; Morange, PE; Poyet, R; Quilici, J | 1 |
Atar, D; Serebruany, VL | 1 |
Hassan, AE; Qureshi, AI; Rodriguez, GJ; Suri, MF; Taylor, RA; Tummala, RP; Vazquez, G; Zacharatos, H | 1 |
Hart, RG | 1 |
Banerjee, A; Bhala, N; Rajasekhar, P; Taggar, JS | 1 |
Alexandrov, AV; Barnwell, SL; Chimowitz, MI; Chiu, D; Clark, JM; Cloft, HJ; Derdeyn, CP; Fiorella, D; Harrigan, MR; Hoh, BL; Hourihane, JM; Janis, LS; Johnson, MD; Klucznik, RP; Lane, BF; Levy, EI; Lutsep, HL; Lynn, MJ; McDougall, CG; Pride, GL; Rumboldt, Z; Torbey, MT; Turan, TN; Waters, MF; Zaidat, OO | 1 |
Arnold-Lloyd, T; Ata, A; Bonville, DJ; Jahraus, CB; Rosati, C; Salem, L; Stain, SC | 1 |
Becker, RC; Husted, S; James, SK; Keltai, M; Khurmi, NS; Lopes, RD; Lopez-Sendon, JL; Mahaffey, KW; Maya, J; Morais, J; Nicolau, JC; Pais, P; Raev, D; Stevens, SR; Storey, RF | 1 |
Ballard, DW; Chettipally, UK; Holmes, JF; Nishijima, DK; Offerman, SR; Rauchwerger, AS; Reed, ME; Vinson, DR | 1 |
Li, J | 1 |
Badellino, M; Moore, MM; Pasquale, MD | 1 |
Aradi, D; Komócsi, A; Serebruany, VL; Vorobcsuk, A | 1 |
Cay, S; Korkmaz, S; Yilmaz, MB | 1 |
Hartung, HP; Nitschmann, S; Siebler, M | 1 |
Hoerauf, H; Horn, W | 1 |
Serebruany, VL | 1 |
13 review(s) available for clopidogrel and Brain Hemorrhage
Article | Year |
---|---|
Efficacy and Safety of Ticagrelor versus Aspirin and Clopidogrel for Stroke Prevention in Patients with Vascular Disease: A Systematic Review and Meta-Analysis.
Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke; Ticagrelor; Treatment Outcome | 2023 |
Head injury in older adults presenting to the ambulance service: who do we convey to the emergency department, and what clinical variables are associated with an intracranial bleed? A retrospective case-control study.
Topics: Aged; Ambulances; Case-Control Studies; Clopidogrel; Craniocerebral Trauma; Emergency Service, Hospital; Humans; Intracranial Hemorrhages; Middle Aged; Observational Studies as Topic; Renal Insufficiency, Chronic; Retrospective Studies | 2023 |
Cilostazol Mono and Combination Treatments in Ischemic Stroke: An Updated Systematic Review and Meta-Analysis.
Topics: Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Drug Therapy, Combination; Humans; Intracranial Hemorrhages; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Secondary Prevention; Stroke | 2019 |
The Role of Platelet Transfusions After Intracranial Hemorrhage in Patients on Antiplatelet Agents: A Systematic Review and Meta-Analysis.
Topics: Brain Injuries, Traumatic; Clopidogrel; Humans; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Platelet Transfusion | 2020 |
Bleeding risk of antiplatelet drugs compared with oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Female; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk; Stroke; Ticlopidine; Treatment Outcome; Vitamin K; Warfarin | 2017 |
Aspirin plus dipyridamole has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, intracranial hemorrhage, and adverse event rate among 7 drug therapies in the treatment of cerebral infarction.
Topics: Aspirin; Cerebral Infarction; Cilostazol; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Hematologic Agents; Humans; Intracranial Hemorrhages; Tetrazoles; Ticlopidine; Warfarin | 2018 |
Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a systematic review and meta-analysis.
Topics: Aged; Aspirin; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2018 |
Closing the loop: a 21-year audit of strategies for preventing stroke and death following carotid endarterectomy.
Topics: Angioscopy; Aspirin; Carotid Artery Diseases; Clinical Protocols; Clopidogrel; Drug Therapy, Combination; Endarterectomy, Carotid; Humans; Hypertension; Intracranial Embolism; Intracranial Hemorrhages; Intraoperative Care; Medical Audit; Platelet Aggregation Inhibitors; Postoperative Care; Practice Guidelines as Topic; Predictive Value of Tests; Quality of Health Care; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Transcranial | 2013 |
Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.
Topics: Anticoagulants; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Risk Assessment; Secondary Prevention; Stroke; Ticlopidine | 2013 |
Reversing the effects of antiplatelet agents in the setting of intracranial hemorrhage: a look at the literature.
Topics: Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Factor VIIa; Humans; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Platelet Transfusion; Recombinant Proteins; Ticlopidine; Treatment Outcome | 2015 |
Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Clopidogrel; Databases, Factual; Gastrointestinal Hemorrhage; Humans; Incidence; Intracranial Hemorrhages; Observational Studies as Topic; Odds Ratio; Risk; Ticlopidine | 2016 |
Anticipating and managing bleeding complications in patients with coronary stents who are receiving dual antiplatelet treatment.
Topics: Blood Component Transfusion; Catheters, Indwelling; Clopidogrel; Coagulants; Coronary Artery Disease; Coronary Restenosis; Drug Interactions; Drug Therapy, Combination; Drug-Eluting Stents; Endoscopy, Gastrointestinal; Fibrinolytic Agents; Forecasting; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Proton Pump Inhibitors; Risk Factors; Stents; Ticlopidine; Treatment Outcome | 2011 |
Impact of clopidogrel and potent P2Y 12 -inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Coronary Thrombosis; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Risk Assessment; Risk Factors; Stroke; Thiophenes; Ticagrelor; Ticlopidine; Treatment Outcome | 2013 |
8 trial(s) available for clopidogrel and Brain Hemorrhage
Article | Year |
---|---|
Clopidogrel loading dose versus maintenance dose to treat patients with acute ischaemic stroke in China (CLASS-China): results from a prospective double-blind randomised clinical trial.
Topics: Aged; China; Clopidogrel; Disease Progression; Double-Blind Method; Early Termination of Clinical Trials; Female; Humans; Intracranial Hemorrhages; Ischemic Stroke; Male; Middle Aged; Patient Selection; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; Secondary Prevention; Time Factors; Treatment Outcome | 2017 |
Dual antiplatelet therapy pretreatment in IV thrombolysis for acute ischemic stroke.
Topics: Administration, Intravenous; Aged; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Stroke; Thrombolytic Therapy; Time Factors; Treatment Outcome; United States | 2018 |
Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Male; Middle Aged; Norway; Pharmacoepidemiology; Risk Factors; Rivaroxaban; Thrombosis; Warfarin | 2018 |
Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial.
Topics: Aged; Aspirin; Brain Ischemia; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Hematuria; Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Secondary Prevention; Severity of Illness Index; Stroke | 2019 |
Stroke in Patients With Peripheral Artery Disease.
Topics: Aged; Clopidogrel; Double-Blind Method; Female; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Middle Aged; Peripheral Arterial Disease; Stroke; Ticagrelor | 2019 |
Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Angiography; Drug Therapy, Combination; Electrocardiography; Enoxaparin; Female; Fibrinolytic Agents; Heart Failure; Humans; Intracranial Hemorrhages; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Tenecteplase; Thrombolytic Therapy; Ticlopidine; Time-to-Treatment; Tissue Plasminogen Activator | 2013 |
Stenting versus aggressive medical therapy for intracranial arterial stenosis.
Topics: Aged; Antihypertensive Agents; Aspirin; Clopidogrel; Combined Modality Therapy; Female; Follow-Up Studies; Health Behavior; Humans; Intracranial Arteriosclerosis; Intracranial Hemorrhages; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Stroke; Ticlopidine | 2011 |
Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attack.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Brain Ischemia; Clopidogrel; Female; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Purinergic P2Y Receptor Antagonists; Risk Factors; Stroke; Ticagrelor; Ticlopidine | 2012 |
52 other study(ies) available for clopidogrel and Brain Hemorrhage
Article | Year |
---|---|
Risk of ischaemic and haemorrhagic stroke in Chinese undergoing percutaneous coronary intervention treated with potent P2Y12 inhibitor versus clopidogrel.
Topics: Acute Coronary Syndrome; Brain Ischemia; China; Clopidogrel; Hemorrhage; Hemorrhagic Stroke; Humans; Intracranial Hemorrhages; Ischemic Stroke; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Stroke; Ticagrelor | 2022 |
Effectiveness and Safety of Clopidogrel vs Aspirin in Elderly Patients With Ischemic Stroke.
Topics: Aged; Aspirin; Cerebral Infarction; Clopidogrel; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Stroke; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Secondary Prevention; Stroke; Treatment Outcome | 2022 |
Natural history of acute unruptured vertebral basilar artery dissection: Temporal changes in imaging findings and contributory factors.
Topics: Basilar Artery; Cerebral Infarction; Clopidogrel; Humans; Intracranial Aneurysm; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Retrospective Studies; Vertebral Artery; Vertebral Artery Dissection | 2022 |
Safety and Efficacy of Baseline Antiplatelet Treatment in Patients Undergoing Mechanical Thrombectomy for Ischemic Stroke: Antiplatelets Before Mechanical Thrombectomy.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Humans; Intracranial Hemorrhages; Ischemic Stroke; Mechanical Thrombolysis; Stroke; Thrombectomy; Thrombolytic Therapy; Treatment Outcome | 2023 |
Dual Antiplatelet Therapy Increases Hemorrhagic Transformation Following Thrombolytic Treatment in Experimental Stroke.
Topics: Animals; Aspirin; Clopidogrel; Coronary Thrombosis; Disease Models, Animal; Drug Therapy, Combination; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Intracranial Hemorrhages; Male; Mice; Platelet Aggregation Inhibitors; Platelet Function Tests; Secondary Prevention; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator | 2019 |
Effect of alteplase versus aspirin plus clopidogrel in acute minor stroke.
Topics: Aged; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Male; Middle Aged; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Retrospective Studies; Severity of Illness Index; Tissue Plasminogen Activator | 2020 |
Disability After Minor Stroke and Transient Ischemic Attack in the POINT Trial.
Topics: Aged; Aspirin; Clopidogrel; Disability Evaluation; Double-Blind Method; Female; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Predictive Value of Tests; Recurrence; Risk Factors; Sex Factors; Stroke; Treatment Outcome | 2020 |
Laboratory assessments of therapeutic platelet inhibition in endovascular neurosurgery: complication prediction using the VerifyNow P2Y12 assay and thromboelastography with platelet mapping.
Topics: Adult; Aged; Blood Platelets; Carotid Arteries; Clopidogrel; Dose-Response Relationship, Drug; Endovascular Procedures; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Stents; Thrombelastography; Thromboembolism; Thrombosis | 2020 |
Impact of Anemia on the Risk of Bleeding Following Percutaneous Coronary Interventions in Patients ≥75 Years of Age.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Anemia; Angina, Unstable; Anticoagulants; Antithrombins; Aspirin; Cause of Death; Clopidogrel; Comorbidity; Coronary Artery Disease; Drug-Eluting Stents; Female; Gastrointestinal Hemorrhage; Hemorrhage; Heparin; Hirudins; Humans; Intracranial Hemorrhages; Kaplan-Meier Estimate; Male; Myocardial Infarction; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Hemorrhage; Prasugrel Hydrochloride; Proportional Hazards Models; Prospective Studies; Recombinant Proteins; Risk Assessment; Stents; Ticagrelor; Urologic Diseases | 2020 |
The Effect of Ticagrelor on Platelet Reactivity in Patients with Clopidogrel Resistance Undergoing Neuroendovascular Procedures.
Topics: Aged; Blood Platelets; Clopidogrel; Endovascular Procedures; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticagrelor; Treatment Outcome | 2020 |
Major bleeding risk and mortality associated with antiplatelet drugs in real-world clinical practice. A prospective cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Cohort Studies; Databases, Factual; Drug Therapy, Combination; Female; France; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Incidence; Intracranial Hemorrhages; Male; Middle Aged; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Young Adult | 2020 |
Risk of Early Bleeding with Dual Antiplatelet Therapy in Acute Stroke and Transient Ischemic Attack Regardless of NIHSS Admission.
Topics: Aged; Aspirin; Brazil; Clopidogrel; Databases, Factual; Disability Evaluation; Drug Administration Schedule; Dual Anti-Platelet Therapy; Female; Functional Status; Humans; Incidence; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Middle Aged; Patient Admission; Platelet Aggregation Inhibitors; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Stroke; Time Factors; Time-to-Treatment; Treatment Outcome | 2021 |
Platelet Function Monitoring Performed after Carotid Stenting during Endovascular Stroke Treatment Predicts Outcome.
Topics: Aged; Aspirin; Carotid Stenosis; Clopidogrel; Databases, Factual; Disability Evaluation; Drug Monitoring; Endovascular Procedures; Female; Humans; Intracranial Hemorrhages; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Stents; Thrombosis; Time Factors; Treatment Outcome | 2021 |
Association between tirofiban monotherapy and efficacy and safety in acute ischemic stroke.
Topics: Aspirin; China; Clopidogrel; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Ischemic Stroke; Prospective Studies; Tirofiban | 2021 |
Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke.
Topics: Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Risk Assessment; Stroke; Ticlopidine; Treatment Outcome | 2021 |
Novel oral anticoagulants and trauma: The results of a prospective American Association for the Surgery of Trauma Multi-Institutional Trial.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Clopidogrel; Dabigatran; Female; Humans; Injury Severity Score; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Ticlopidine; Trauma Centers; Warfarin; Wounds and Injuries; Wounds, Nonpenetrating | 2017 |
Platelet transfusion to reverse antiplatelet therapy before decompressive surgery in patients with intracranial haemorrhage.
Topics: Adult; Aged; Aged, 80 and over; Clopidogrel; Decompression, Surgical; Female; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Transfusion; Preoperative Care; Stroke; Thrombosis; Ticlopidine | 2017 |
Nonsteroidal anti-inflammatory drug choice and adverse outcomes in clopidogrel users: A retrospective cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Brain Ischemia; Clopidogrel; Drug Interactions; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Incidence; Intracranial Hemorrhages; Medicaid; Middle Aged; Mortality; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Ticlopidine; United States; Young Adult | 2018 |
Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS Registry.
Topics: Acute Coronary Syndrome; Age Factors; Aged; Asia; Brazil; Canada; Clopidogrel; Decision Support Techniques; Erythrocyte Transfusion; Europe; Female; Humans; Incidence; Intracranial Hemorrhages; Male; Middle Aged; Patient Discharge; Patient Readmission; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Predictive Value of Tests; Registries; Risk Assessment; Risk Factors; Ticagrelor; Time Factors; Treatment Outcome | 2018 |
Preventing arteriovenous shunt failure in hemodialysis patients: a population-based cohort study.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arteriovenous Shunt, Surgical; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Vessel Prosthesis Implantation; Clopidogrel; Databases, Factual; Female; Gastrointestinal Hemorrhage; Graft Occlusion, Vascular; Humans; Intracranial Hemorrhages; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation Inhibitors; Protective Factors; Renal Dialysis; Retrospective Studies; Risk Assessment; Risk Factors; Taiwan; Thrombosis; Treatment Failure; Warfarin; Young Adult | 2019 |
Increased Use of Ticagrelor After Myocardial Infarction Is Not Associated With Intracranial Hemorrhage.
Topics: Age Factors; Aged; Clopidogrel; Cohort Studies; Female; Humans; Intracranial Hemorrhages; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Proportional Hazards Models; Secondary Prevention; Sweden; Ticagrelor | 2018 |
Clopidogrel Drug Interactions and Serious Bleeding: Generating Real-World Evidence via Automated High-Throughput Pharmacoepidemiologic Screening.
Topics: Aged; Aged, 80 and over; Clopidogrel; Databases, Factual; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Pharmacoepidemiology; Platelet Aggregation Inhibitors | 2019 |
Short-term bleeding events observed with clopidogrel loading in acute ischemic stroke patients.
Topics: Aged; Brain Ischemia; Clopidogrel; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine; Treatment Outcome | 2013 |
Risk of hemorrhagic complication associated with ventriculoperitoneal shunt placement in aneurysmal subarachnoid hemorrhage patients on dual antiplatelet therapy.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Female; Humans; Hydrocephalus; Intracranial Aneurysm; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Prosthesis Implantation; Risk; Subarachnoid Hemorrhage; Ticlopidine; Ventriculoperitoneal Shunt | 2013 |
Early dual therapy for Chinese adults with TIA.
Topics: Aspirin; China; Clopidogrel; Drug Therapy, Combination; Female; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine | 2013 |
Initial experiences with Multiplate® for rapid assessment of antiplatelet agent activity in neurosurgical emergencies.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Arachidonic Acid; Aspirin; Clopidogrel; Embolization, Therapeutic; Emergencies; Emergency Medical Services; Female; Hemostatic Techniques; Humans; Intracranial Hemorrhages; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Transfusion; Point-of-Care Systems; Ticlopidine | 2013 |
Repeat head computed tomography in anticoagulated traumatic brain injury patients: still warranted.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain Injuries; Clopidogrel; Cohort Studies; Disease Progression; Female; Head Injuries, Closed; Humans; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Multivariate Analysis; Registries; Retrospective Studies; Risk Factors; Ticlopidine; Tomography, X-Ray Computed; Warfarin | 2014 |
The roles and issues of P2Y12 percent inhibition assessed by VerifyNow assay for patients undergoing Neurointervention: a prospective study.
Topics: Aged; Brain Ischemia; Clopidogrel; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticlopidine; Treatment Outcome | 2014 |
The significance of platelet count in traumatic brain injury patients on antiplatelet therapy.
Topics: Aged; Aspirin; Brain Injuries; Clopidogrel; Female; Humans; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Platelet Count; Prospective Studies; ROC Curve; Ticlopidine; Tomography, X-Ray Computed | 2014 |
Intracranial hemorrhage during dual antiplatelet therapy after percutaneous left atrial appendage closure.
Topics: Aged; Aspirin; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 2014 |
Incidence of intracranial hemorrhage and outcomes after ground-level falls in geriatric trauma patients taking preinjury anticoagulants and antiplatelet agents.
Topics: Accidental Falls; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Female; Humans; Intracranial Hemorrhages; Logistic Models; Male; Multivariate Analysis; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Ticlopidine; Warfarin | 2014 |
Preinjury warfarin, but not antiplatelet medications, increases mortality in elderly traumatic brain injury patients.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Brain Injuries; Clopidogrel; Female; Humans; Intracranial Hemorrhages; Length of Stay; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Survival Rate; Ticlopidine; Tomography, X-Ray Computed; Trauma Severity Indices; Warfarin | 2015 |
Unfractionated heparin-clopidogrel combination in ST-elevation myocardial infarction not receiving reperfusion therapy.
Topics: Aged; Anticoagulants; Clopidogrel; Drug Therapy, Combination; Enoxaparin; Europe; Female; Fibrinolytic Agents; Health Care Surveys; Heparin; Hospital Mortality; Humans; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Propensity Score; Registries; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome | 2015 |
A New Protocol for Anticoagulation With Tirofiban During Flow Diversion.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clinical Protocols; Clopidogrel; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Intracranial Aneurysm; Intracranial Hemorrhages; Intraoperative Care; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Tirofiban; Tyrosine | 2016 |
Antithrombotic Medication Use and Misuse Among Patients with Intracranial Hemorrhage: A 16-Year, Lebanese, Single-Center Experience.
Topics: Acenocoumarol; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebral Hemorrhage; Clopidogrel; Coronary Artery Disease; Enoxaparin; Female; Fibrinolytic Agents; Humans; Inappropriate Prescribing; Intracranial Hemorrhages; Lebanon; Male; Middle Aged; Platelet Aggregation Inhibitors; Prescription Drug Misuse; Retrospective Studies; Risk Factors; Stroke; Ticlopidine; Warfarin; Young Adult | 2016 |
Association between antithrombotic treatment and hemorrhagic stroke in patients with atrial fibrillation-a cohort study in primary care.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Primary Health Care; Stroke; Sweden; Ticlopidine; Warfarin | 2017 |
Post-PCI fatal bleeding in aspirin and clopidogrel hyper responder: shifting from antiplatelet resistance to bleeding risk assessment?
Topics: Acute Coronary Syndrome; Aspirin; Blood Platelets; Clopidogrel; Fatal Outcome; Female; Humans; Intracranial Hemorrhages; Middle Aged; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Ticlopidine | 2010 |
Predictors of mortality in trauma patients with intracranial hemorrhage on preinjury aspirin or clopidogrel.
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation Tests; Brain Injuries; Case-Control Studies; Cause of Death; Clopidogrel; Female; Geriatric Assessment; Glasgow Coma Scale; Hospital Mortality; Humans; Intracranial Hemorrhages; Male; Middle Aged; Multiple Trauma; Predictive Value of Tests; Probability; Prognosis; Reference Values; Retrospective Studies; Risk Assessment; Survival Analysis; Ticlopidine; Tomography, X-Ray Computed; Trauma Centers | 2008 |
Acute reversal of clopidogrel-related platelet inhibition using methyl prednisolone in a patient with intracranial hemorrhage.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Clopidogrel; Female; Humans; Intracranial Hemorrhages; Methylprednisolone; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 2008 |
ACTIVE A: balancing the benefits and risks of clopidogrel and aspirin.
Topics: Aged; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Female; Humans; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Risk; Stroke; Ticlopidine | 2009 |
Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome. Shifting from antiplatelet resistance to bleeding risk assessment?
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; Biomarkers; Cell Adhesion Molecules; Clopidogrel; Coronary Artery Bypass; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Microfilament Proteins; Middle Aged; Patient Discharge; Phosphoproteins; Phosphorylation; Pilot Projects; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Risk Assessment; Ticlopidine; Time Factors; Treatment Outcome | 2009 |
The PLATO trial: do you believe in magic?
Topics: Acute Coronary Syndrome; Adenosine; Clinical Trials, Phase III as Topic; Clopidogrel; Humans; Intracranial Hemorrhages; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Ticagrelor; Ticlopidine; Treatment Outcome | 2010 |
Low risk of intracranial and systemic hemorrhages in patients on dual antiplatelet treatment beyond 1 month following neuroendovascular angioplasty and/or stent placement.
Topics: Angioplasty; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Combined Modality Therapy; Comorbidity; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Minnesota; Platelet Aggregation Inhibitors; Prevalence; Radiography; Risk Assessment; Risk Factors; Stents; Survival Analysis; Survival Rate; Ticlopidine; Treatment Outcome | 2012 |
The unmet need of patients with atrial fibrillation: AVERROES and the novel oral anticoagulants.
Topics: Angiotensin II Type 1 Receptor Blockers; Anticoagulants; Aspirin; Atrial Fibrillation; Biphenyl Compounds; Clinical Trials, Phase III as Topic; Clopidogrel; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Irbesartan; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Stroke; Tetrazoles; Ticlopidine | 2011 |
Impact of preinjury warfarin and antiplatelet agents on outcomes of trauma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Child; Child, Preschool; Clopidogrel; Cohort Studies; Female; Humans; Infant; Intracranial Hemorrhages; Length of Stay; Male; Middle Aged; Multivariate Analysis; New York; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Risk Factors; Ticlopidine; Trauma Centers; Warfarin; Wounds and Injuries; Young Adult | 2011 |
Immediate and delayed traumatic intracranial hemorrhage in patients with head trauma and preinjury warfarin or clopidogrel use.
Topics: Aged; Aged, 80 and over; Anticoagulants; Clopidogrel; Craniocerebral Trauma; Emergency Service, Hospital; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Risk; Ticlopidine; Time Factors; Tomography, X-Ray Computed; Warfarin | 2012 |
Validation of the dime.
Topics: Anticoagulants; Clopidogrel; Craniocerebral Trauma; Female; Humans; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin | 2012 |
Impact of age and anticoagulation: need for neurosurgical intervention in trauma patients with mild traumatic brain injury.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Brain Injuries; Clopidogrel; Craniotomy; Decompressive Craniectomy; Glasgow Coma Scale; Humans; Intracranial Hemorrhages; Middle Aged; Retrospective Studies; Ticlopidine; Time Factors; Tomography, X-Ray Computed; Warfarin | 2012 |
Intracranial bleeding associated with clopidogrel.
Topics: Aged; Angioplasty, Balloon, Coronary; Antihypertensive Agents; Clopidogrel; Coronary Stenosis; Humans; Hypertension; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine; Tomography, X-Ray Computed | 2005 |
[Cerebral secondary prevention--clopidogrel alone or in combination with ASS].
Topics: Aged; Aspirin; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Ticlopidine; Treatment Outcome | 2005 |
[Intravitreal injections during anticoagulant treatment].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; Aspirin; Bevacizumab; Choroidal Neovascularization; Clopidogrel; Conjunctival Diseases; Humans; Injections; Intracranial Hemorrhages; Macular Degeneration; Phenprocoumon; Platelet Aggregation Inhibitors; Prospective Studies; Ranibizumab; Risk Factors; Ticlopidine; Triamcinolone; Vitreous Body; Vitreous Hemorrhage | 2008 |
Bleeding risks with prasugrel in the TRITON trial: good news ... bad news.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Clopidogrel; Drug Therapy, Combination; Hematemesis; Hematuria; Hemorrhage; Humans; Intracranial Hemorrhages; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Thiophenes; Ticlopidine | 2008 |